Mark Fendrick, MD

Mark Fendrick, MD, is a professor and director of the Center for Value-Based Insurance Design at the University of Michigan.

Articles by Mark Fendrick, MD

How FDA Approval of SimpleScreen CRC Could Expand Colorectal Cancer Screening With Mark Fendrick, MD

ByMark Fendrick, MD

July 27th 2026

FDA approves Freenome's SimpleScreen CRC blood test for colorectal cancer screening in average-risk adults aged 45 years and older.

The Environmental Impact of Colorectal Cancer Screening, with Mark Fendrick, MD

ByMark Fendrick, MD

May 5th 2025

Fendrick describes patients’ desire for green screening options and reviews findings from a study comparing the environmental impact of screening tools.

Optimizing Follow-Up Colonoscopy Rates for CRC Screening, with Mark Fendrick, MD

ByMark Fendrick, MD

May 4th 2025

Fendrick describes the importance of follow-up colonoscopy after a positive result on a noninvasive test and factors influencing follow-up rates.

Mark Fendrick, MD

Articles by Mark Fendrick, MD

How FDA Approval of SimpleScreen CRC Could Expand Colorectal Cancer Screening With Mark Fendrick, MD

The Environmental Impact of Colorectal Cancer Screening, with Mark Fendrick, MD

Optimizing Follow-Up Colonoscopy Rates for CRC Screening, with Mark Fendrick, MD

Latest Updated Articles

Trending on HCPLive

FDA Approves Freenome Blood Test for Colorectal Cancer Screening

Rethinking Advanced Heart Failure: Treat the Disease, Not the Symptoms

Early Detection and Treatment Advances in IgA Nephropathy, With Ramy Hanna, MD

Sebetralstat Shows QoL Gains on Top of HAE Prophylaxis in KONFIDENT-S

Can We Stop Heart Failure at Its Source?